Reaction Details Report a problem with these data
Target
Kallikrein-1
Ligand
BDBM408768
Substrate
n/a
Meas. Tech.
Inhibitory Activity Assay
IC50
>40000±n/a nM
Citation
 Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors US Patent  US11001578 Publication Date 5/11/2021 
Target
Name:
Kallikrein-1
Synonyms:
Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein | KLK1_HUMAN | KLK1 | Kallikrein 1
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Human
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM408768
Synonyms:
US10364238, Example 77 | N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2- | US10730874, Example 00398 | US11198691, Example 77 | US11001578, Example 77 | US11084809, Example 77 | US11352356, Table II.4
Type:
Small organic molecule
Emp. Form.:
TBD
Mol. Mass.:
TBD
SMILES:
TBD
Structure:
Search PDB for entries with ligand similarity: